IRIS
BIONDI, BERNADETTE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.474
EU - Europa 4.267
AS - Asia 4.186
SA - Sud America 560
AF - Africa 99
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.299
SG - Singapore 2.306
RU - Federazione Russa 1.886
HK - Hong Kong 819
CN - Cina 704
IT - Italia 623
BR - Brasile 506
UA - Ucraina 345
FI - Finlandia 319
IE - Irlanda 295
DE - Germania 276
SE - Svezia 201
CA - Canada 139
NL - Olanda 114
GB - Regno Unito 89
IN - India 69
VN - Vietnam 61
TR - Turchia 51
PK - Pakistan 47
FR - Francia 34
BD - Bangladesh 27
IQ - Iraq 27
MX - Messico 25
ZA - Sudafrica 25
AR - Argentina 21
EG - Egitto 21
CI - Costa d'Avorio 17
CZ - Repubblica Ceca 17
AT - Austria 15
AU - Australia 13
SA - Arabia Saudita 13
CO - Colombia 11
PL - Polonia 10
KE - Kenya 9
UZ - Uzbekistan 9
EC - Ecuador 8
IR - Iran 8
KR - Corea 8
JO - Giordania 7
LY - Libia 7
MA - Marocco 7
HU - Ungheria 6
JP - Giappone 6
BG - Bulgaria 5
ES - Italia 5
TN - Tunisia 5
VE - Venezuela 5
CL - Cile 4
EU - Europa 4
IL - Israele 4
RO - Romania 4
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
ET - Etiopia 2
LT - Lituania 2
MC - Monaco 2
PE - Perù 2
PS - Palestinian Territory 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 13.609
Salva come PNG Salva come JPEG
Città #
Singapore 1.293
Hong Kong 818
Chandler 556
Moscow 511
Jacksonville 360
Millbury 357
Princeton 286
Nanjing 265
Santa Clara 226
Naples 163
Boston 155
Ashburn 132
Wilmington 126
Woodbridge 123
Ottawa 115
Amsterdam 95
Napoli 87
Beijing 75
Nanchang 69
Ann Arbor 59
Houston 55
Shenyang 54
Norwalk 49
Munich 45
Dong Ket 44
Kronberg 43
Des Moines 42
Hebei 39
Jiaxing 38
Lahore 37
São Paulo 34
Seattle 33
Falls Church 32
Afragola 31
Changsha 31
Lawrence 31
Los Angeles 28
Boardman 25
Tianjin 24
Kunming 20
Dublin 19
Helsinki 18
Belo Horizonte 16
Durham 16
Nuremberg 16
Rome 16
The Dalles 16
Brooklyn 15
Hefei 15
New York 15
Brno 14
Milan 13
Cagliari 12
Frankfurt am Main 12
Turku 12
Rio de Janeiro 11
Shanghai 11
Cairo 10
Dhaka 10
Toronto 10
Ho Chi Minh City 9
Redmond 9
Sydney 9
Washington 9
Baghdad 8
Brasília 8
Chicago 8
Dallas 8
Johannesburg 8
London 8
Orange 8
Tashkent 8
Vienna 8
Curitiba 7
Erbil 7
Fairfield 7
Indiana 7
Kochi 7
Nairobi 7
San Francisco 7
Tripoli 7
Amman 6
Bacoli 6
Belém 6
Caxias do Sul 6
Fortaleza 6
Guarulhos 6
Hangzhou 6
Mexico City 6
Mountain View 6
Mumbai 6
Santa Maria Capua Vetere 6
Seoul 6
São Gonçalo 6
Buenos Aires 5
Changchun 5
Dearborn 5
Falkenstein 5
Guangzhou 5
Jeddah 5
Totale 7.155
Salva come PNG Salva come JPEG
Nome #
Thyroid and obesity: an intriguing relationship 213
Impact of hyperthyroidism and its correction on vascular reactivity in humans. 101
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 88
Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer 84
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly 82
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 81
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 76
Subclinical hyperthyroidism: clinical features and treatment options. 74
Cardovascular safety of acute recombinant human thyrotropin administration in patients monitored for differentiated thyroid cancer. 73
Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency 73
Combination treatment with T4 and T3: Toward personalized replacement therapy in hypothyroidism? 72
Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. 68
Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation 68
Cardiac effects of GH 67
Cardiovascular involvement in patients with different causes of hyperthyroidism. 67
“Ruolo della PET (tomografia ad emissione di positroni) con 2-(18F)Fluoro-2-Desossiglucosio (FDG) nel carcinoma differenziato della tiroide” 67
Thyrotropin (tsh) directly and acutely affects vascular reactivity in humans 67
Endogenous subclinical hyperthyroidism: who, when and why to treat 66
Hypothyroidism as a risk factor for cardiovascular disease. 66
INCREASED ARTERIAL INTIMA-MEDIA THICKNESS IN CHILDHOOD-ONSET GROWTH HORMONE DEFICIENCY. 66
Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications 66
Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid Cancer Patients. 65
Screening and treatment for subclinical thyroid disease. 65
Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. 65
Impact of pituitary adenomas on the heart. Pituitary tumors: Epidemiology, Pathogenesis and Management : 64
A new marker for diagnosis of thyroid papillary cancer: B-flow twinkling sign. 64
Control of adrenergic overactivity by beta-blockade improves quality of life in patients on long-term suppressive therapy with levo-thyroxine. 63
Treatment With Thyroid Hormone. 62
Maternal thyroid parameters, body mass index and subsequent weight gain during pregnancy in healthy euthyroid women. 61
Effects of thyroid hormone on the cardiovascular system. 61
Gender differences in the prevalence, clinical features and response tro cabergoline in hyperprolactinemia 61
Patients with subclinical Cushing’s syndrome have increased cardiovascular risk 61
Thyroid hormone therapy for hypothyroidism. 61
Identical HLA antigens in two sisters with MEN IIA syndrome. J Endocrinol Invest. 1994 Mar;17(3):205-6. 61
New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours 61
Usefulness of 111In-Octreotide scintigraphy in Von-Hippel-Lindau disease. 61
Enhancement of vascular endothelial function by recombinant human thyrotropin 60
Abnormalities of left ventricular structure and function in adult patients with growth hormone deficiency. 59
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 59
How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings? 59
Severe hypothyroidism due to the loss of therapeutic efficacy of L-thyroxine in a patient with esophageal complication associated with systemic sclerosis 59
Recombinant human thyrotropin reduces serum vascular endothelial growth factor levels in patients monitored for thyroid carcinoma even in the absence of thyroid tissue. 57
Organizzatrice del Symposio satellite “ The cardiovascular risk at the various stages of the thyroid failure”, 31st European Thyroid Association Meeting 57
Benefits of thyrotropin suppression versus the risks of adverse effects 57
Longitudinal study of thyroid autoimmunity and function, before, during and after recombinant interferone alfa-2a (fIFN -2a) therapy. 57
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism 57
Critical Approach to Hypothyroid Patients With Persistent Symptoms 56
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. 56
Effetti sul cuore della terapia tireosoppressiva a lungo termine. 56
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 56
2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: Clinical indications and controversies in diagnosis and follow-up 56
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 55
Thyroid B-flow twinkling sign: a new feature of papillary cancer 55
2007-2009 Editorial Board Member del “ Journal of Clinical Endocrinology and Metabolism”. “ 55
Utilizzo del TSH ricombinante nella diagnostica del carcinoma differenziato della tiroide:trials multicentrici di validazione 55
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 55
Cardiac effects of long-term thyrotropin suppressive therapy with levothyroxine. 54
Impact of hyperthyroidism and its correction on vascular reactivity in humans . 54
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. 54
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. 54
Invited lecture, ETA-CRN Meeting Presentation title: “TSH suppression and the heart”. 54
“Effetti cardiovascolari delle patologie subcliniche della tiroide”. Aggiornamento di Endocrinologia di Franco Orio e Francesco Orio. Giuseppe De Nicola editore 54
Mortality in elderly patients with subclinical hyperthyroidism. 53
Aldosterone receptor blockade in the management of heart failure. 53
Flow Cytometry Phenotypization of Intrathyroidal Lymphoid Infiltrate and Thyroidal Functional Status in Hashimoto Thyroiditis on Fine-Needle Cytology Samples 53
Fertility in 32 patients receiving 131 I therapy for thyroid cancer 53
Impact of pituitary adenomas on the heart. 53
The normal TSH reference range: what has changed in the last decade? 53
Valutazione degli intervalli di tempo sistolici nel follow-up post-chirurgico dei carcinomi differenziati della tiroide 52
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 52
Diastolic dysfunction in patients on TSH-suppressive therapy with levo-thyroxine: effect of beta-blockade. 51
Endogenous subclinical hyperthyropidism affects quality of life and cardiac morphology and function iin young and middle-aged patients. 51
Subclinical hypothyroidism and cardiac function. 51
A preliminary study of growth hormone in the treatment of heart failure in patients with dilated cardiomyopathy. 51
Aldosterone receptors' blockade in the management of heart failure in elderly patients. 51
Recenti tecniche diagnostiche nel follow-up post chirurgico del carcinoma midollare della tiroide (CMT): cateterizzazione venosa selettiva (CVS) e scintigrafia con 131 I metaiodobenzilguanidina (131 I MIBG). 51
Short-term combined treatment with L-thyroxine plus L-triiodothyronine (LT4 plus LT3) drops in patients with persistent hypothyroidism and malabsorption during replacement therapy with LT4 51
Spindle epithelial tumor with thymus-like differentiation (SETTLE): clinical-pathological features, differential pathological diagnosis and therapy. 51
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 50
Role of the neck ultrasonography, of thyroglobulin after rhTSH and of FDGPET in post surgical follow-up of differentiated thyroid cancer 50
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 50
Effects of subclinical thyroid dysfunction on the heart. 49
Patients with Subclinical Cushing’s Syndrome due to Adrenal Adenoma have increased Cardiovascular risk. 49
Heart in Hyperthyroidism: A Comprehensive Guide for the Clinicians 49
Impaired cardiac reserve and exercise capacity in patients on long-term thyrotropin suppressive therapy with levothyroxine. 48
Effetti dell'ipotiroidismo acuto sul cuore. 48
Effetti dell'ipotiroidismo acuto sul cuore. 48
The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence. 48
American Thyroid Association 48
The potential role of CXCRA and SDF1 as indicators of tumor aggressiveness in patients with conventinal papillary thyroid carcinoma 48
Editorial Board 48
Enhancement of vascular endothelial function by recombinant human thyrotropin. 48
Beneficial effect of doxazosin versus pheonoxibenzamine in pre-operative management of patients with pheochrmocitoma 48
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine 48
Persistent Dyslipidemia in Patients With Hypothyroidism: A Good Marker for Personalized Replacement Therapy? 48
Thyroid Hormone Suppression Therapy 48
The Clinical Significance of Subclinical Thyroid Dysfunction. 47
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. 47
heart failure caused by dilated cardiomyopathy : rationale for treatment with growth hormone. 47
ItalianPheochromocytoma/Paraganglioma Network. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional ornonfunctional paragangliomas. 47
Totale 5.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 29 78 94 65 83 127 88 15 95 23 81 49
2021/20221.462 18 1 4 15 27 66 12 71 294 68 152 734
2022/20231.382 325 64 19 118 153 167 13 132 199 103 58 31
2023/2024981 41 126 61 38 57 43 13 89 25 38 244 206
2024/20256.448 463 676 38 61 101 169 724 313 882 659 1.706 656
2025/2026671 671 0 0 0 0 0 0 0 0 0 0 0
Totale 13.970